REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 30 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $162,000 | -40.0% | 318,965 | +9.2% | 0.00% | – |
| Q4 2018 | $270,000 | +3.8% | 292,166 | +100.0% | 0.00% | – |
| Q3 2018 | $260,000 | +26.8% | 146,083 | 0.0% | 0.00% | – |
| Q2 2018 | $205,000 | -6.8% | 146,083 | 0.0% | 0.00% | – |
| Q1 2018 | $220,000 | -25.4% | 146,083 | 0.0% | 0.00% | – |
| Q4 2017 | $295,000 | -16.4% | 146,083 | 0.0% | 0.00% | – |
| Q3 2017 | $353,000 | -15.3% | 146,083 | 0.0% | 0.00% | – |
| Q2 2017 | $417,000 | – | 146,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|